• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[酰化纤溶酶原激活剂 - 链激酶复合物与纤维蛋白的结合及体外纤溶反应]

[Binding of an acylated plasminogen activator-streptokinase complex with fibrin and the fibrinolytic response in vitro].

作者信息

Aĭsina R B, Zhitkova Iu V, Varfolomeev S D

出版信息

Vopr Med Khim. 1994 May-Jun;40(3):31-5.

PMID:8079435
Abstract

Affinity and fibrinolytic properties of streptokinase and two new preparations of acylated plasminogen-streptokinase activator complexes, produced by dissimilar procedures, were studied. Even after 1-min exposure, blood clot lysis carried out by the acyl activating complex was continued in blood plasma more than for 4 hrs, while the streptokinase produced blood clot lysis was accomplished within 1.5 hrs. After 1-min contact with clot in blood plasma the rates of lysis by streptokinase and these acylated plasminogen-streptokinase activator complexes types 1 and 2 constituted 23%, 37% and 63%, respectively, as compared with the rates detected during permanent contact of thrombolytics with blood clot. The activator properties of the thrombolytic agents itself and its stability in blood plasma were of importance even in similar affinity ability of free and acylated activating complexes.

摘要

研究了链激酶以及通过不同程序制备的两种新型酰化纤溶酶原-链激酶激活剂复合物的亲和力和纤溶特性。即使经过1分钟的暴露,酰化激活复合物在血浆中进行的血凝块溶解仍持续超过4小时,而链激酶产生的血凝块溶解在1.5小时内完成。与溶栓剂与血凝块持续接触期间检测到的速率相比,在血浆中与凝块接触1分钟后,链激酶以及1型和2型这些酰化纤溶酶原-链激酶激活剂复合物的溶解速率分别为23%、37%和63%。即使游离和酰化激活复合物具有相似的亲和力,溶栓剂本身的激活特性及其在血浆中的稳定性也很重要。

相似文献

1
[Binding of an acylated plasminogen activator-streptokinase complex with fibrin and the fibrinolytic response in vitro].[酰化纤溶酶原激活剂 - 链激酶复合物与纤维蛋白的结合及体外纤溶反应]
Vopr Med Khim. 1994 May-Jun;40(3):31-5.
2
[Fibrinolysis in vitro by acylated derivatives of a plasmin-streptokinase activator complex].[纤溶酶-链激酶激活剂复合物酰化衍生物的体外纤维蛋白溶解作用]
Ukr Biokhim Zh (1978). 1991 Mar-Apr;63(2):27-31.
3
[Effectiveness of acylated thrombolytic agents in lysis of blood plasma clots from humans and various animals].[酰化溶栓剂对人及多种动物血浆凝块的溶解效果]
Ukr Biokhim Zh (1978). 1991 Mar-Apr;63(2):31-9.
4
[The thrombolytic activity of acylated activator complexes of plasmin-streptokinase with different rates of reactivation].[纤溶酶-链激酶不同再激活率的酰化激活剂复合物的溶栓活性]
Farmakol Toksikol. 1991 Mar-Apr;54(2):46-50.
5
The interaction of streptokinase.plasminogen activator complex, tissue-type plasminogen activator, urokinase and their acylated derivatives with fibrin and cyanogen bromide digest of fibrinogen. Relationship to fibrinolytic potency in vitro.链激酶 - 纤溶酶原激活物复合物、组织型纤溶酶原激活物、尿激酶及其酰化衍生物与纤维蛋白及纤维蛋白原溴化氰消化产物的相互作用。与体外纤溶活性的关系。
Biochem J. 1987 Oct 15;247(2):395-400. doi: 10.1042/bj2470395.
6
In vitro comparison of fibrinolytic activity of plasminogen activators using a thrombelastographic method: in vivo evaluation of the B-chain-streptokinase complex in the dog model using pre-titered doses.使用血栓弹力图法对纤溶酶原激活剂的纤溶活性进行体外比较:在犬模型中使用预滴定剂量对B链-链激酶复合物进行体内评估。
Thromb Haemost. 1986 Aug 20;56(1):71-9.
7
Acyl-enzymes as thrombolytic agents in a rabbit model of venous thrombosis.酰基酶作为静脉血栓形成兔模型中的溶栓剂。
Thromb Haemost. 1982 Jun 28;47(3):269-74.
8
Fibrin-specificity of a plasminogen activator affects the efficiency of fibrinolysis and responsiveness to ultrasound: comparison of nine plasminogen activators in vitro.纤溶酶原激活剂的纤维蛋白特异性影响纤维蛋白溶解效率及对超声的反应性:九种纤溶酶原激活剂的体外比较
Thromb Haemost. 1999 Apr;81(4):605-12.
9
Functional properties of p-anisoylated plasmin-staphylokinase complex.
Thromb Haemost. 1993 Aug 2;70(2):326-31.
10
Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.用于靶向溶栓的纤维蛋白靶向全氟碳纳米颗粒。
Nanomedicine (Lond). 2007 Aug;2(4):533-43. doi: 10.2217/17435889.2.4.533.